English
简体中文
Total: £ 56.28
Published Date: 2026-04-08 | Pages: 125 | Tables: 124 | Pharma & Healthcare
The global Taxol market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Taxol competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Taxol is a chemotherapy medication primarily used to treat various types of cancer. Its active ingredient is paclitaxel, which is derived from the bark of the Pacific yew tree (Taxus brevifolia) or, more commonly, synthesized in the laboratory. Taxol works by interfering with the growth and division of cancer cells. Specifically, it binds to tubulin, a protein involved in cell division, and stabilizes microtubules, preventing them from breaking down. This disruption in microtubule dynamics ultimately leads to cell cycle arrest and apoptosis (programmed cell death) in cancer cells. Taxol is used to treat a variety of cancers, including breast cancer, ovarian cancer, lung cancer, and Kaposi's sarcoma. It is typically administered intravenously by a healthcare professional in a clinical setting. While Taxol can be effective in treating cancer, it may also cause side effects, including hair loss, nausea, vomiting, diarrhea, neuropathy (nerve damage), and bone marrow suppression. The severity and type of side effects experienced can vary from person to person.
The North American market for Taxol is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Taxol is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Taxol include Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Taxol market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Taxol. The Taxol market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Taxol market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Taxol manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius-kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
Segment by Type
Natural Paclitaxel API
Semi-synthetic Paclitaxel API
by Application
Ovarian Cancer
Cervical Cancer
Breast Cancer
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Taxol manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Taxol sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Taxol Market Overview
1.1 Product Definition
1.2 Taxol by Type
1.2.1 Global Taxol Market Value by Type: 2025 vs 2032
1.2.2 Natural Paclitaxel API
1.2.3 Semi-synthetic Paclitaxel API
1.3 Taxol by Application
1.3.1 Global Taxol Market Value by Application: 2025 vs 2032
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Global Taxol Market Size Estimates and Forecasts
1.4.1 Global Taxol Revenue 2021–2032
1.4.2 Global Taxol Sales 2021–2032
1.4.3 Global Taxol Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Taxol Market Competition by Manufacturers
2.1 Global Taxol Sales Market Share by Manufacturers (2021–2026)
2.2 Global Taxol Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Taxol Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Taxol, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Taxol, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Taxol, Product Types and Applications
2.7 Global Key Manufacturers of Taxol, Date of Entry into the Industry
2.8 Global Taxol Market Competitive Situation and Trends
2.8.1 Global Taxol Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Taxol Players Market Share by Revenue
2.8.3 Global Taxol Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Taxol Market Scenario by Region
3.1 Global Taxol Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Taxol Sales by Region: 2021–2032
3.2.1 Global Taxol Sales by Region: 2021–2026
3.2.2 Global Taxol Sales by Region: 2027–2032
3.3 Global Taxol Revenue by Region: 2021–2032
3.3.1 Global Taxol Revenue by Region: 2021–2026
3.3.2 Global Taxol Revenue by Region: 2027–2032
3.4 North America Taxol Market Facts & Figures by Country
3.4.1 North America Taxol Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Taxol Sales by Country (2021–2032)
3.4.3 North America Taxol Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Taxol Market Facts & Figures by Country
3.5.1 Europe Taxol Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Taxol Sales by Country (2021–2032)
3.5.3 Europe Taxol Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Taxol Market Facts & Figures by Region
3.6.1 Asia Pacific Taxol Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Taxol Sales by Region (2021–2032)
3.6.3 Asia Pacific Taxol Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Taxol Market Facts & Figures by Country
3.7.1 Latin America Taxol Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Taxol Sales by Country (2021–2032)
3.7.3 Latin America Taxol Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Taxol Market Facts & Figures by Country
3.8.1 Middle East and Africa Taxol Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Taxol Sales by Country (2021–2032)
3.8.3 Middle East and Africa Taxol Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Taxol Sales by Type (2021–2032)
4.1.1 Global Taxol Sales by Type (2021–2026)
4.1.2 Global Taxol Sales by Type (2027–2032)
4.1.3 Global Taxol Sales Market Share by Type (2021–2032)
4.2 Global Taxol Revenue by Type (2021–2032)
4.2.1 Global Taxol Revenue by Type (2021–2026)
4.2.2 Global Taxol Revenue by Type (2027–2032)
4.2.3 Global Taxol Revenue Market Share by Type (2021–2032)
4.3 Global Taxol Price by Type (2021–2032)
5 Segment by Application
5.1 Global Taxol Sales by Application (2021–2032)
5.1.1 Global Taxol Sales by Application (2021–2026)
5.1.2 Global Taxol Sales by Application (2027–2032)
5.1.3 Global Taxol Sales Market Share by Application (2021–2032)
5.2 Global Taxol Revenue by Application (2021–2032)
5.2.1 Global Taxol Revenue by Application (2021–2026)
5.2.2 Global Taxol Revenue by Application (2027–2032)
5.2.3 Global Taxol Revenue Market Share by Application (2021–2032)
5.3 Global Taxol Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Phyton
6.1.1 Phyton Company Information
6.1.2 Phyton Description and Business Overview
6.1.3 Phyton Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Phyton Taxol Product Portfolio
6.1.5 Phyton Recent Developments/Updates
6.2 ScinoPharm
6.2.1 ScinoPharm Company Information
6.2.2 ScinoPharm Description and Business Overview
6.2.3 ScinoPharm Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 ScinoPharm Taxol Product Portfolio
6.2.5 ScinoPharm Recent Developments/Updates
6.3 Novasep
6.3.1 Novasep Company Information
6.3.2 Novasep Description and Business Overview
6.3.3 Novasep Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Novasep Taxol Product Portfolio
6.3.5 Novasep Recent Developments/Updates
6.4 Samyang
6.4.1 Samyang Company Information
6.4.2 Samyang Description and Business Overview
6.4.3 Samyang Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Samyang Taxol Product Portfolio
6.4.5 Samyang Recent Developments/Updates
6.5 Polymed
6.5.1 Polymed Company Information
6.5.2 Polymed Description and Business Overview
6.5.3 Polymed Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Polymed Taxol Product Portfolio
6.5.5 Polymed Recent Developments/Updates
6.6 TAPI (Teva)
6.6.1 TAPI (Teva) Company Information
6.6.2 TAPI (Teva) Description and Business Overview
6.6.3 TAPI (Teva) Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 TAPI (Teva) Taxol Product Portfolio
6.6.5 TAPI (Teva) Recent Developments/Updates
6.7 Fresenius-kabi
6.7.1 Fresenius-kabi Company Information
6.7.2 Fresenius-kabi Description and Business Overview
6.7.3 Fresenius-kabi Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Fresenius-kabi Taxol Product Portfolio
6.7.5 Fresenius-kabi Recent Developments/Updates
6.8 Huiang biopharma
6.8.1 Huiang biopharma Company Information
6.8.2 Huiang biopharma Description and Business Overview
6.8.3 Huiang biopharma Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Huiang biopharma Taxol Product Portfolio
6.8.5 Huiang biopharma Recent Developments/Updates
6.9 Southpharma
6.9.1 Southpharma Company Information
6.9.2 Southpharma Description and Business Overview
6.9.3 Southpharma Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Southpharma Taxol Product Portfolio
6.9.5 Southpharma Recent Developments/Updates
6.10 Yunnan Hande
6.10.1 Yunnan Hande Company Information
6.10.2 Yunnan Hande Description and Business Overview
6.10.3 Yunnan Hande Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Yunnan Hande Taxol Product Portfolio
6.10.5 Yunnan Hande Recent Developments/Updates
6.11 Hainan Yew Pharm
6.11.1 Hainan Yew Pharm Company Information
6.11.2 Hainan Yew Pharm Description and Business Overview
6.11.3 Hainan Yew Pharm Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hainan Yew Pharm Taxol Product Portfolio
6.11.5 Hainan Yew Pharm Recent Developments/Updates
6.12 Jiangsu Yew Biotechnology
6.12.1 Jiangsu Yew Biotechnology Company Information
6.12.2 Jiangsu Yew Biotechnology Description and Business Overview
6.12.3 Jiangsu Yew Biotechnology Taxol Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Jiangsu Yew Biotechnology Taxol Product Portfolio
6.12.5 Jiangsu Yew Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Taxol Industry Chain Analysis
7.2 Taxol Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Taxol Production Mode & Process Analysis
7.4 Taxol Sales and Marketing
7.4.1 Taxol Sales Channels
7.4.2 Taxol Distributors
7.5 Taxol Customer Analysis
8 Taxol Market Dynamics
8.1 Taxol Industry Trends
8.2 Taxol Market Drivers
8.3 Taxol Market Challenges
8.4 Taxol Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Taxol Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Taxol Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Taxol Market Competitive Situation by Manufacturers in 2025
Table 4. Global Taxol Sales (K Dose) of Key Manufacturers (2021–2026)
Table 5. Global Taxol Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Taxol Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Taxol Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Taxol Average Price (US$/Dose) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Taxol, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Taxol, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Taxol, Product Types and Applications
Table 12. Global Key Manufacturers of Taxol, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Taxol Companies by Tier (Tier 1, Tier 2, Tier 3), based on Taxol Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Taxol Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Taxol Sales by Region (K Dose), 2021–2026
Table 18. Global Taxol Sales Market Share by Region (2021–2026)
Table 19. Global Taxol Sales by Region (K Dose), 2027–2032
Table 20. Global Taxol Sales Market Share by Region (2027–2032)
Table 21. Global Taxol Revenue by Region (US$ Million), 2021–2026
Table 22. Global Taxol Revenue Market Share by Region (2021–2026)
Table 23. Global Taxol Revenue by Region (US$ Million), 2027–2032
Table 24. Global Taxol Revenue Market Share by Region (2027–2032)
Table 25. North America Taxol Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Taxol Sales by Country (K Dose), 2021–2026
Table 27. North America Taxol Sales by Country (K Dose), 2027–2032
Table 28. North America Taxol Revenue by Country (US$ Million), 2021–2026
Table 29. North America Taxol Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Taxol Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Taxol Sales by Country (K Dose), 2021–2026
Table 32. Europe Taxol Sales by Country (K Dose), 2027–2032
Table 33. Europe Taxol Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Taxol Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Taxol Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Taxol Sales by Region (K Dose), 2021–2026
Table 37. Asia Pacific Taxol Sales by Region (K Dose), 2027–2032
Table 38. Asia Pacific Taxol Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Taxol Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Taxol Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Taxol Sales by Country (K Dose), 2021–2026
Table 42. Latin America Taxol Sales by Country (K Dose), 2027–2032
Table 43. Latin America Taxol Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Taxol Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Taxol Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Taxol Sales by Country (K Dose), 2021–2026
Table 47. Middle East and Africa Taxol Sales by Country (K Dose), 2027–2032
Table 48. Middle East and Africa Taxol Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Taxol Revenue by Country (US$ Million), 2027–2032
Table 50. Global Taxol Sales (K Dose) by Type (2021–2026)
Table 51. Global Taxol Sales (K Dose) by Type (2027–2032)
Table 52. Global Taxol Sales Market Share by Type (2021–2026)
Table 53. Global Taxol Sales Market Share by Type (2027–2032)
Table 54. Global Taxol Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Taxol Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Taxol Revenue Market Share by Type (2021–2026)
Table 57. Global Taxol Revenue Market Share by Type (2027–2032)
Table 58. Global Taxol Price (US$/Dose) by Type (2021–2026)
Table 59. Global Taxol Price (US$/Dose) by Type (2027–2032)
Table 60. Global Taxol Sales (K Dose) by Application (2021–2026)
Table 61. Global Taxol Sales (K Dose) by Application (2027–2032)
Table 62. Global Taxol Sales Market Share by Application (2021–2026)
Table 63. Global Taxol Sales Market Share by Application (2027–2032)
Table 64. Global Taxol Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Taxol Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Taxol Revenue Market Share by Application (2021–2026)
Table 67. Global Taxol Revenue Market Share by Application (2027–2032)
Table 68. Global Taxol Price (US$/Dose) by Application (2021–2026)
Table 69. Global Taxol Price (US$/Dose) by Application (2027–2032)
Table 70. Phyton Company Information
Table 71. Phyton Description and Business Overview
Table 72. Phyton Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 73. Phyton Taxol Product
Table 74. Phyton Recent Developments/Updates
Table 75. ScinoPharm Company Information
Table 76. ScinoPharm Description and Business Overview
Table 77. ScinoPharm Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 78. ScinoPharm Taxol Product
Table 79. ScinoPharm Recent Developments/Updates
Table 80. Novasep Company Information
Table 81. Novasep Description and Business Overview
Table 82. Novasep Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 83. Novasep Taxol Product
Table 84. Novasep Recent Developments/Updates
Table 85. Samyang Company Information
Table 86. Samyang Description and Business Overview
Table 87. Samyang Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 88. Samyang Taxol Product
Table 89. Samyang Recent Developments/Updates
Table 90. Polymed Company Information
Table 91. Polymed Description and Business Overview
Table 92. Polymed Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 93. Polymed Taxol Product
Table 94. Polymed Recent Developments/Updates
Table 95. TAPI (Teva) Company Information
Table 96. TAPI (Teva) Description and Business Overview
Table 97. TAPI (Teva) Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 98. TAPI (Teva) Taxol Product
Table 99. TAPI (Teva) Recent Developments/Updates
Table 100. Fresenius-kabi Company Information
Table 101. Fresenius-kabi Description and Business Overview
Table 102. Fresenius-kabi Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 103. Fresenius-kabi Taxol Product
Table 104. Fresenius-kabi Recent Developments/Updates
Table 105. Huiang biopharma Company Information
Table 106. Huiang biopharma Description and Business Overview
Table 107. Huiang biopharma Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 108. Huiang biopharma Taxol Product
Table 109. Huiang biopharma Recent Developments/Updates
Table 110. Southpharma Company Information
Table 111. Southpharma Description and Business Overview
Table 112. Southpharma Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 113. Southpharma Taxol Product
Table 114. Southpharma Recent Developments/Updates
Table 115. Yunnan Hande Company Information
Table 116. Yunnan Hande Description and Business Overview
Table 117. Yunnan Hande Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 118. Yunnan Hande Taxol Product
Table 119. Yunnan Hande Recent Developments/Updates
Table 120. Hainan Yew Pharm Company Information
Table 121. Hainan Yew Pharm Description and Business Overview
Table 122. Hainan Yew Pharm Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 123. Hainan Yew Pharm Taxol Product
Table 124. Hainan Yew Pharm Recent Developments/Updates
Table 125. Jiangsu Yew Biotechnology Company Information
Table 126. Jiangsu Yew Biotechnology Description and Business Overview
Table 127. Jiangsu Yew Biotechnology Taxol Sales (K Dose), Revenue (US$ Million), Price (US$/Dose), and Gross Margin (2021–2026)
Table 128. Jiangsu Yew Biotechnology Taxol Product
Table 129. Jiangsu Yew Biotechnology Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Taxol Distributors List
Table 133. Taxol Customers List
Table 134. Taxol Market Trends
Table 135. Taxol Market Drivers
Table 136. Taxol Market Challenges
Table 137. Taxol Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Taxol
Figure 2. Global Taxol Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Taxol Market Share by Type: 2025 & 2032
Figure 4. Natural Paclitaxel API Product Picture
Figure 5. Semi-synthetic Paclitaxel API Product Picture
Figure 6. Global Taxol Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Taxol Market Share by Application: 2025 & 2032
Figure 8. Ovarian Cancer
Figure 9. Cervical Cancer
Figure 10. Breast Cancer
Figure 11. Others
Figure 12. Global Taxol Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Taxol Market Size (US$ Million), 2021–2032
Figure 14. Global Taxol Sales (K Dose), 2021–2032
Figure 15. Global Taxol Average Price (US$/Dose), 2021–2032
Figure 16. Taxol Report Years Considered
Figure 17. Taxol Sales Share by Manufacturers in 2025
Figure 18. Global Taxol Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Taxol Players: Market Share by Revenue in Taxol in 2025
Figure 20. Taxol Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Taxol Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Taxol Sales Market Share by Country (2021–2032)
Figure 23. North America Taxol Revenue Market Share by Country (2021–2032)
Figure 24. United States Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Taxol Sales Market Share by Country (2021–2032)
Figure 27. Europe Taxol Revenue Market Share by Country (2021–2032)
Figure 28. Germany Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Taxol Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Taxol Revenue Market Share by Region (2021–2032)
Figure 35. China Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Taxol Sales Market Share by Country (2021–2032)
Figure 43. Latin America Taxol Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Taxol Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Taxol Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Taxol Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Taxol by Type (2021–2032)
Figure 54. Global Revenue Market Share of Taxol by Type (2021–2032)
Figure 55. Global Taxol Price (US$/Dose) by Type (2021–2032)
Figure 56. Global Sales Market Share of Taxol by Application (2021–2032)
Figure 57. Global Revenue Market Share of Taxol by Application (2021–2032)
Figure 58. Global Taxol Price (US$/Dose) by Application (2021–2032)
Figure 59. Taxol Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
